Today, the United States Food and Drug Administration announced that “GlaxoSmithKline (GSK) Consumer Healthcare is voluntarily recalling all alli® weight loss products from U.S. and Puerto Rico retailers as the company believes that some packages of the product were tampered with and may contain product that is not authentic alli®.” www.fda.gov
Some of the packages are believed to contain pills and capsules of various sizes and colors that are not authentic to Alli, which comes as a turquoise blue capsule with a dark blue band and the text “60 Orlistat”. Some states that are involved are: Alabama, Florida, Louisiana, Mississippi, New York, North Carolina and Texas. Packages in those states had been tampered with missing tablets or possible substitutions. GlaxoSmithKline (GSK) officially launched an investigation on Wednesday after receiving a number of consumer complaints. It is working with the U.S. Food and Drug Administration and is encouraging consumers to cooperate with the probe, alerting the company if they inadvertently purchase any suspicious bottles. Colin Mackenzie, GSK’s President, Consumer Healthcare North America stated “We are committed to finding out what happened and to doing everything possible to prevent future issues.” www.foxbusiness.com Mackenzie followed up by stating ““Safety is our first priority and we are asking retailers and pharmacies to remove all Alli from their shelves immediately. www.foxbusiness.com
GlaxoSmithKline manufactures alli in South Carolina, however, the drug giant has manufacturing facilities in both the U.S. and Puerto Rico.The medication an over the counter diet product, is a turquoise blue capsule with a dark blue band imprinted with the text “60 Orlistat”. It is packaged in a labeled bottle that has an inner foil seal imprinted with the words: “Sealed for Your Protection.” Consumers should confirm any alli® in their possession matches this description. www.fda.gov
Customers who have purchased the alli weight loss products should contact GlaxoSmithKline at 800-671-2554, and a representative will provide further instructions. If they have consumed the questionable product, they should also contact their healthcare providers.